Medical device firm BD, along with its charitable affiliate BD Foundation, has committed $7.8m in monetary grants and product donations over the next three years to support BDHelping Build Healthy Communities initiative to help community health centers.
BDHelping Build Healthy Communities is a public-private partnership launched in 2013.
It is implemented jointly by Direct Relief and the National Association of Community Health Centers (NACHC).
Grants are given by the BD Helping Build Healthy Communities to community health centres that implement innovative approaches to offer quality healthcare to underserved populations in the US.
Since 2013, BD has invested almost $15.7m in cash and product donations to this initiative.
This latest financial commitment from BD and the BD Foundation will bring their combined investment to $22.6m, through the year 2022.
This year represents the first time that the BD Foundation, which was set up in 2017 following the company’s acquisition of C. R. Bard, has made a financial contribution to this initiative.
Community health centres serve close to 30 million patients nationwide. These patients suffer various chronic ailments including diabetes, hypertension, and other health issues that serve as risk factors for Covid-19.
BD president and CEO Tom Polen said: “Community health centers have long played an integral role in delivering quality, affordable healthcare to the most vulnerable patients in the United States.
“As economic and other burdens caused by Covid-19 make it more challenging than ever for at-risk patients to manage chronic conditions, this initiative aims to provide funding to help health centers expand their healthcare innovations to reach more patients.”
Health centres that have earlier received funding through this initiative have developed new models for assisting vulnerable people in managing complex chronic diseases.
Later this month, BD, the BD Foundation, Direct Relief and NACHC will urge health centres to apply for the initiative’s next round of grant funding.
The awards will be given for innovative approaches in medication therapy management services for better chronic disease management among patients.